Herpes Cure And Treatment

Herpes Resistant To Acyclovir

Acyclovir-resistant herpes simplex virus (HSV) has become increasingly common, particularly among patients with human immunodeficiency virus (HIV).

HSV drug resistance to acyclovir infers broad cross-resistance to this entire class of antiviral agents. (See Acyclovir: An overview, section on ‘Mechanism of action’. Background. Occasional cases of acyclovir resistance have been documented in the treatment of herpes simplex virus (HSV) infection. Thirty-eight subjects with acyclovir-resistant infections were identified in an epidemiological surveillance program involving 1811 HSV-infected subjects in France. Considering taking medication to treat Acyclovir-Resistant HSV Infections? Below is a list of common medications used to treat or reduce the symptoms of Acyclovir-Resistant HSV Infections.

Treatment Of Drug-resistant Genital Herpes Simplex Virus Infection In Hiv-infected Patients

Most alarmingly, HSV strains being resistant to both TK-dependent drugs as well as polymerase inhibitors have been isolated from highly immunocompromised patients undergoing stem cellbone marrow transplantation (12, 13). Original Article from The New England Journal of Medicine Recurrent Acyclovir-Resistant Genital Herpes in an Immunocompetent Patient.

Which one of the following would be the most effective therapy at this point for presumptive acyclovir-resistant herpes simplex virus infection? A. Topical Imiquimod Treatment of Aciclovir-resistant Herpes Simplex Disease. Case Series and Literature Review. Nicky Perkins; Mitzi Nisbet; Mark Thomas. The difference between love and herpes is that herpes is forever. At the present time, foscarnet (Foscavir) is the most common treatment for acyclovir-resistant herpes. The drug must be administered via an intravenous (IV) line, usually three times a day, often in a hospital or under the close supervision of an in-home nurse.

Acyclovir-resistant Herpes Simplex Virus Infection

Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine. This study has been completed. In vitro, acyclovir triphosphate stops replication of herpes viral DNA. Drug Resistance: Resistance of HSV and VZV to acycl ovir can result from qualitative and quantitative changes in the viral TK andor DNA polymerase. Herpes is a virus that infects the nervous system, modifying the DNA of the nerve cells supplying the skin through which the virus entered. A number of strains of HSV which are resistant to acyclovir, valacyclovir, and Famvir have been discovered. Acyclovir-resistant HSV (ACV-R-HSV) infections were first described in 1982. 1 To date, over 100 patients with ACV-R-HSV infection have been identified. Infection because of herpes simplex virus (HSV) that is resistant to acyclovir (ACV) poses treatment challenges in hematopoietic cell transplant (HCT) patients. Herpes antivirals do not eradicate the virus, which is recurrent and lifelong. Acyclovir-resistant HSV strains that exhibit thymidine kinase deficiency are also resistant to famciclovir and penciclovir. Using the dye uptake testing method, the laboratory determined this HSV-1 to be highly resistant to acyclovir, in that the minimal inhibitory concentration (MIC) was 48 gmL. Treatment of Acyclovir-Resistant Herpes Simplex Virus with Continuous Infusion of High-Dose Acyclovir in Hematopoietic Cell Transplant Patients. Janet H. Kim. Foscarnet Therapy for Severe Acyclovir-Resistant Herpes Simplex Virus Type-2 Infections in Patients with the Acquired Immunodeficiency Syndrome (AIDS) : An Uncontrolled Trial.


Real Time Web Analytics
Scroll To Top